Menbuton

Products Menbuton is commercially available as a solution for injection. It has been approved in many countries since 1962. Structure and properties Menbutone (C15H14O4, Mr = 258.3 g/mol) Effects Menbutone (ATCvet QA05AX90) has secretory effects (bile, pancreatic juice) in the digestive tract. Indications To stimulate secretion in the digestive tract of ruminants, horses, pigs, and … Menbuton

Crotetamide

Products Crotetamide is commercially available as a veterinary drug in the form of drops in combination with cropropamide. It has been approved in many countries since 1968. Structure and properties Crotetamide (C12H22N2O2, Mr = 226.3 g/mol) Effects Crotetamide (ATCvet QR07AB99) stimulates the respiratory center and improves depth of breath. Indications For respiratory stimulation in cattle, … Crotetamide

Thiamazole

Products Thiamazole is approved in the form of film-coated tablets and as [solution for injection>injections] (Thiamazol Henning, Germany). In many countries, it is commercially available only as a veterinary drug for cats. This article refers to human use. Thiamazole is also known as methimazole. Structure and properties Thiamazole (C4H6N2S, Mr = 114.2 g/mol) is a … Thiamazole

Thiostrepton

Products Thiostrepton is marketed as a lotion in combination with other active ingredients. It has been approved in many countries since 1973. Effects Thiostrepton (ATCvet QD07CB01) has antibacterial properties effective against Gram-positive and Gram-negative pathogens of skin infections. Indications Skin diseases (veterinary drug).

Slimming Products

Effects Antiadiposita differ in their effects. They inhibit appetite or increase satiety, reduce the absorption of food components in the intestine or promote their utilization, increase energy metabolism and degrading metabolic processes. The ideal slimming agent would enable rapid, high and stable weight loss and at the same time be very well tolerated and applicable … Slimming Products

Proligeston

Products Proligeston is commercially available as an injection suspension. It has been approved in many countries since 1979. Structure and properties Proligestone (C24H34O4, Mr = 386.5 g/mol) is a synthetic progestin. Effects Proligestone (ATCvet QG03DA90) has progestogenic and antigonodotrophic properties. Indications For estrus regulation in bitches, cats, and ferrets.

Propentofylline

Products Propentofylline is a form of film-coated tablets commercially available (Karsivan). It has been approved in many countries since 1986. This article refers to its use in dogs. Structure and properties Propentofylline (C15H22N4O3, Mr = 306.4 g/mol) is a xanthine derivative. Effects Propentofylline (ATCvet QC04AD90) is blood flow-promoting in the microcirculation and indirectly platelet aggregation-inhibiting, … Propentofylline

Cropropamide

Products Cropropamide is commercially available in the form of drops in combination with crotetamide as a veterinary drug. It has been approved in many countries since 1968. Structure and properties Cropropamide (C10H13ClN2O3S, Mr = 276.7 g/mol) Effects Cropropamide (ATCvet QR07AB99) stimulates the respiratory center and improves depth of breath. Indications For respiratory stimulation in cattle, … Cropropamide

Carfentanil

Products In many countries, no drugs containing carfentanil are on the market. The active ingredient is used in veterinary medicine (Wildnil). Legally, it belongs to narcotics. Structure and properties Carfentanil (C24H30N2O3, Mr = 394.5 g/mol) is structurally closely related to fentanyl, being 4-methoxycarbonylfentanyl. Carfentanil citrate is present in pharmaceuticals. The active ingredient was developed at … Carfentanil

Moxidectin

Products Moxidectin is commercially available as a mono- and combination preparation as a solution, injection solution, oral gel, and spot-on preparation for animals. It has been approved in many countries since 1999. In 2018, a drug was approved in the U.S. for the treatment of onchocerciasis (river blindness). Structure and properties Moxidectin (C37H53NO8, Mr = … Moxidectin

Lokivetmab

Products Lokivetmab was approved in the EU in 2017 and in many countries in 2018 in the form of a solution for injection (Cytopoint, Zoetis Belgium SA). Lokivetmab was the first monoclonal antibody to be cleared for animals. In the United States, locivetmab was approved in 2015 (Canine Atopic Dermatitis Immunotherapeutic). Structure and properties Lokivetmab … Lokivetmab

Valnemulin

Products Valnemulin is commercially available as a drug premix. It has been approved in many countries since 2002. Structure and properties Valnemulin (C31H52N2O5S, Mr = 564.8 g/mol) Effects Valnemulin (ATCvet QJ01XQ02) has antibacterial properties. The effects are based on inhibition of bacterial protein synthesis. Indications Treatment and prevention of swine dysentery.